The Underwriting-Realization Test

Every underwriting model carries a margin assumption that gets tested exactly once — the day a buyer asks about it. Between deal close and exit, that assumption sits unverified, inherited by whoever manages the company, restated in every subsequent projection, and never independently confirmed. This is not a diligence failure. It is the absence of a governance step that most sponsors have never built.

Roughly three in four sponsors currently underwrite margin improvement of up to three hundred basis points between purchase and sale. The industry's own benchmark research states plainly that the difficulty is not making this assumption — it is capturing whether it was ever true, after the deal closes. That admission, from the institution whose report anchors more Investment Committee memos than any other, is the operating problem this Playbook exists to solve.

The enterprise value objective is exit multiple protection. Buyers do not discount companies for weak numbers. They discount companies for improvement claims they cannot independently verify — a distinction sellers rarely name because they rarely recognize it as the reason the multiple compressed. The management behavior that must change: every material margin assumption gets tested for traceability, independence, and durability at a fixed point during the hold, by someone other than the person who built the original model — not discovered for the first time when a sale process begins.

This Playbook exists because the industry has confirmed, in its own words, that this test currently does not happen as a matter of course. It should.

A margin assumption that has never been independently tested against reality is a forecast, not a fact — regardless of how rigorously it was built.

This matters because enterprise value at exit depends on the credibility of the improvement claim, not merely its magnitude. A 300-basis-point margin gain that can be traced to a specific operating event, confirmed by someone outside the original deal team, and shown to persist without the current owner's involvement is a fundamentally different asset than the same 300 basis points supported only by "the model said this would happen, and EBITDA is higher now than it was at entry." Buyers already price the difference. Most sellers currently don't know which version of their own story they're telling.

It is repeatable because it does not depend on company size, sector, or deal structure — it depends only on the existence of a material margin assumption in the underwriting model, which exists in nearly every transaction. It creates enterprise value because it converts an invisible risk — unverifiable improvement — into a visible, addressable one, while there is still time to strengthen the asset before a sale process forces the question.

Primary owner: Operating Partner, assigned independently of the original deal team for each asset under test.

Secondary participants: CFO (financial traceability), Investment Committee (receives and acts on results), Board (uses results to inform hold/exit timing).

When to use this Playbook: Any portfolio company past year two of its hold with a material margin improvement assumption in its original underwriting model. It applies equally to a first platform investment and a fifth add-on.

When not to use it: This Playbook does not apply to revenue growth assumptions, working capital initiatives, or newly closed deals still inside their first operating year — those require different diagnostics. It also does not apply once an exit process has already commenced; by that point, verification should already exist as a record, not be initiated as a defense.

Required preconditions: The original underwriting model must be accessible in its original form; a materiality threshold for testable assumptions must be set at the portfolio level; an Operating Partner independent of the deal team must be assigned.

Expected outcomes: A documented verification status for every material margin assumption in the portfolio, reviewed by the Investment Committee before any hold/exit timing decision is made.

Typical implementation mistakes: Allowing the original deal team to self-certify the test (defeats the independence requirement); running the test only at exit preparation (defeats its entire purpose); treating a passed test as permanent rather than re-confirming durability as circumstances change; setting the materiality threshold so high that meaningful assumptions escape testing entirely.

Stage One: Portfolio Inventory
Purpose: Establish which assets carry untested material margin assumptions.
Inputs: Underwriting models for every active portfolio company; current hold-period length for each.
Executive decisions: Set the materiality threshold; prioritize assets by proximity to exit or by hold-period length.
Actions: Compile a single portfolio-wide list of material margin assumptions with test status (untested, in progress, passed, failed).
Outputs: A portfolio verification register.
Governance checkpoint: Presented to the Investment Committee as a baseline, not a performance review.
Evidence of progress: A complete, accurate register exists where none did before.
Failure indicator: The register cannot be compiled because underwriting models are not consistently accessible or documented — a finding in itself.

Stage Two: Independent Assignment
Purpose: Ensure the test is not conducted by the people who built the original assumption.
Inputs: Portfolio verification register; Operating Partner staffing.
Executive decisions: Assign an Operating Partner to each asset with no prior involvement in that asset's original underwriting.
Actions: Formal assignment, communicated to portfolio company management as a standard governance step — not an audit triggered by suspicion.
Outputs: A named, independent owner for each test.
Governance checkpoint: Investment Committee confirms independence before testing begins.
Evidence of progress: No Operating Partner is testing an assumption they originally modeled.
Failure indicator: Staffing constraints result in deal-team members conducting their own tests — this should be treated as a portfolio-level resourcing problem, not accepted as a workaround.

Stage Three: Evidence Collection
Purpose: Gather the operational detail necessary to test traceability.
Inputs: Financial statements; management's account of what produced any realized margin change; underlying contracts, pricing actions, or cost decisions.
Executive decisions: Determine what constitutes sufficient evidence of a specific operating event, versus an inferred trend.
Actions: Operating Partner requests, from management, the specific decision or event behind each claimed improvement — not a restated financial summary.
Outputs: A documented evidentiary basis for each assumption, or documented absence of one.
Governance checkpoint: None yet — this stage is diagnostic, not decisional.
Evidence of progress: Each assumption now has either supporting evidence or a clear gap identified.
Failure indicator: Management cannot produce anything beyond "EBITDA is higher than it was at entry" — this is itself the finding the test is designed to surface.

Stage Four: Application of the Test
Purpose: Formally score each assumption against Traceability, Independence, and Durability.
Inputs: Evidence gathered in Stage Three.
Executive decisions: Classify each assumption as verified or unverified based on how many of the three criteria it satisfies.
Actions: Operating Partner documents a pass/fail determination for each criterion, with supporting rationale.
Outputs: A completed Underwriting-Realization Test result for each material assumption.
Governance checkpoint: Result delivered to the Investment Committee as a standing agenda item.
Evidence of progress: Every material assumption in the portfolio carries a documented, dated test result.
Failure indicator: Results are produced but not reviewed, or reviewed without any resulting action.

Stage Five: Investment Committee Action
Purpose: Convert the test result into an actual governance decision.
Inputs: Completed test results across the portfolio.
Executive decisions: For failed assumptions — does this change hold/exit timing? Does it trigger corrective action (handed to a separate re-underwriting Playbook)? Does it change how the asset is currently described internally or to LPs?
Actions: Formal Investment Committee record of the decision made in response to each test result.
Outputs: A documented linkage between verification status and portfolio strategy.
Governance checkpoint: This is itself the primary governance checkpoint of the entire Playbook.
Evidence of progress: At least one hold/exit or corrective-action decision has been directly informed by a test result.
Failure indicator: Test results accumulate in a file with no visible influence on any Investment Committee decision — at which point the Playbook exists on paper but not in practice.

The Underwriting-Realization Test.

For each material margin assumption, ask three questions:

How to use it: Apply per assumption, not per company — a single portfolio company may carry several distinct margin assumptions, each requiring its own test.

When to use it: At the mid-hold checkpoint (typically year three), and again before any exit-readiness discussion, regardless of whether the mid-hold test already occurred.

Who owns each decision: The Operating Partner owns the test itself. The Investment Committee owns the resulting decision — whether to adjust hold/exit timing, initiate corrective action, or revise how the asset's improvement story is represented.

How disagreements should be resolved: If the Operating Partner and portfolio company management disagree about whether an assumption passes, the disagreement itself should be escalated to the Investment Committee as evidence — a contested assumption is, by definition, not independently verified, regardless of which side is ultimately correct.

An assumption passing fewer than two of three criteria is classified as unverified enterprise value and must be escalated before any exit-readiness conversation begins.

Decision rights: The Operating Partner has authority to initiate and conduct the test at any point during the hold, without requiring deal-team approval — this authority must be explicit and protected, or the independence requirement collapses in practice.

Information flow: Evidence flows from portfolio company management to the Operating Partner; test results flow from the Operating Partner to the Investment Committee; the original deal team receives the result but does not control it.

Authority: Rests with the Operating Partner for conducting the test, and with the Investment Committee for acting on it.

Accountability: The Investment Committee is accountable for demonstrating that verification status informed at least one material portfolio decision per year — a test result with no consequence is a governance failure, not a neutral outcome.

Meeting cadence: Verification status is a standing Investment Committee agenda item at the mid-hold checkpoint for each asset, and again at any exit-readiness discussion.

Board involvement: The board receives verification status at least once during the hold — this should not be reserved for exit preparation.

Executive review process: Annual portfolio-wide review of aggregate verification status — what proportion of material assumptions across the portfolio are currently verified versus unverified — presented as a standing sponsor-level metric, not company by company.

Daily: No activity.

Weekly: No standing activity.

Monthly: Operating Partner monitors for any assumption approaching materiality ahead of schedule — for example, an unsolicited buyer inquiry that would force premature verification.

Quarterly: Standard operating review confirms which assets are approaching, or have passed, their scheduled mid-hold checkpoint.

Annually: Full Underwriting-Realization Test conducted for any asset reaching year three of the hold; re-confirmed at year five if still held; portfolio-wide verification status reviewed at the sponsor level.

At exit preparation: Test results are reviewed as an existing record. This is the central discipline the Playbook enforces — verification should never be initiated for the first time once a sale process has begun.

Leading indicators: Percentage of material margin assumptions with a documented test result at any point in time; time elapsed between deal close and first scheduled test.

Lagging indicators: Ratio of assumptions discovered as unverified during exit preparation versus discovered at mid-hold — this ratio should shift decisively toward mid-hold discovery as the Playbook matures.

Executive KPIs: Portfolio-wide percentage of material assumptions currently classified as verified.

Board KPIs: Verification status for any asset under active hold/exit timing discussion.

Buyer diligence indicators: Availability of a documented, independently-produced verification trail for any margin improvement claim presented in a sale process — this is the single indicator most directly connected to buyer confidence and exit multiple.

Most common failure: The test is conducted, or effectively conducted, by the same team that built the original assumption — eliminating the independence the entire Playbook depends on. Occurs because staffing an Operating Partner independent of every deal is genuinely difficult at smaller sponsors. Early warning sign: no test in the portfolio has ever failed. Recovery action: rotate Operating Partner assignments across deal teams explicitly to preserve independence, even at some staffing cost.

Second most common failure: Verification becomes a paperwork exercise — a checkbox exercise satisfied by restating the model rather than gathering independent evidence. Early warning sign: test documentation reads identically to the original underwriting narrative. Recovery action: require the Operating Partner to identify a specific operating event for each assumption, not a financial trend.

Governance failure: Investment Committee receives failed test results without acting on them. Early warning sign: a failed test exists on file with no corresponding change to hold/exit timing or corrective action plan. Recovery action: make the test result a mandatory, documented input to any hold/exit timing decision — not a background reference.

Leadership behavior that unintentionally undermines implementation: Framing the test as an audit of the deal team's original judgment, which invites defensiveness and quiet resistance. The correct framing, communicated explicitly by sponsor leadership: this protects exit value, it does not relitigate past decisions.

If implemented successfully, a buyer conducting diligence encounters something rare: a margin improvement claim supported by a documented, independently-produced verification trail rather than a restated model. The diligence question that currently stalls most sale processes — "how do you know this margin improvement is real and will hold under new ownership" — has an evidenced answer instead of an inferred one.

What becomes more transferable is the improvement itself. A buyer can underwrite a traceable, independently-confirmed operating history far more confidently than a projection presented as settled fact. Exit readiness improves specifically at the point sellers currently lose the most value — not because the underlying numbers change, but because the evidence behind them does.

This Playbook is designed to standardize across every company in the portfolio, regardless of sector — the test applies to any material margin assumption, in any industry, at any company size. What should never be compromised: the independence of the Operating Partner conducting the test, and the requirement that Investment Committee action follow every test result. Where customization is appropriate: the materiality threshold, which may reasonably differ by company size, and the specific evidence standard for traceability, which will look different in a manufacturing business than in a services business. Sponsors maintain consistency by governing the test at the portfolio level — a single standing Investment Committee agenda item and a single portfolio-wide verification register — rather than allowing each deal team to define its own version of "verified."

This Playbook is worth implementing because the alternative — discovering an unverified assumption during a live sale process — is the most expensive possible moment to learn it.

The opportunity cost of ignoring this Playbook is a silent, unmeasured exit multiple discount that the sponsor never sees applied and therefore never corrects for. The recurring management problem it eliminates is the annual scramble, during exit preparation, to retroactively justify margin claims that were never tested when there was still time to strengthen them.

The recurring board discussion it improves is hold/exit timing — currently informed by a restated model, and after implementation, informed by evidence.

This Playbook establishes the first concrete governance instrument built on the Underwriting-Realization Gap research — the operational conversion of "modeled versus verified EBITDA" into a repeatable, assignable, measurable discipline.

It depends on no prior Playbook and assumes none. Future Playbooks that depend on it: a Re-Underwriting Protocol for assets that fail the test, and a Value Creation Origination Standard addressing how margin assumptions should be evidenced at the point they are first modeled — closing the loop this Playbook only diagnoses.

Future Research Journals addressing exit multiple compression, DPI suppression, or track record durability should reference this Playbook as the operational counterpart to that research.

It belongs in the chapter of the future Operating System addressing how operating value creation is governed across the hold period — the first instrument in that chapter with an assignable owner, a fixed cadence, and a measurable outcome.

An Operating Partner implementing this Playbook in 2033 would find its logic unchanged: the test does not depend on the 2026 multiple environment, current fundraising conditions, or any temporary market pressure — those explain why the underlying gap became newly visible, not why the test is necessary.

As long as underwriting models continue to contain margin assumptions built with more rigor than they are later verified — a condition with no evident expiration — this Playbook continues to protect enterprise value, strengthen governance, and improve buyer confidence exactly as designed.